nodes	percent_of_prediction	percent_of_DWPC	metapath
Tiagabine—CYP3A4—Tamoxifen—pancreatic cancer	0.0534	0.24	CbGbCtD
Tiagabine—CYP3A4—Erlotinib—pancreatic cancer	0.0454	0.204	CbGbCtD
Tiagabine—CYP3A4—Irinotecan—pancreatic cancer	0.041	0.185	CbGbCtD
Tiagabine—CYP3A4—Docetaxel—pancreatic cancer	0.0301	0.135	CbGbCtD
Tiagabine—CYP3A4—Sunitinib—pancreatic cancer	0.0299	0.135	CbGbCtD
Tiagabine—CYP3A4—Doxorubicin—pancreatic cancer	0.0224	0.101	CbGbCtD
Tiagabine—Anaemia—Docetaxel—pancreatic cancer	0.000451	0.000579	CcSEcCtD
Tiagabine—Gastritis—Doxorubicin—pancreatic cancer	0.000447	0.000575	CcSEcCtD
Tiagabine—Muscular weakness—Doxorubicin—pancreatic cancer	0.000446	0.000573	CcSEcCtD
Tiagabine—Vomiting—Sunitinib—pancreatic cancer	0.000444	0.000571	CcSEcCtD
Tiagabine—Body temperature increased—Gemcitabine—pancreatic cancer	0.000443	0.00057	CcSEcCtD
Tiagabine—Dysuria—Epirubicin—pancreatic cancer	0.000441	0.000567	CcSEcCtD
Tiagabine—Rash—Sunitinib—pancreatic cancer	0.00044	0.000566	CcSEcCtD
Tiagabine—Dermatitis—Sunitinib—pancreatic cancer	0.00044	0.000566	CcSEcCtD
Tiagabine—Urticaria—Fluorouracil—pancreatic cancer	0.000438	0.000563	CcSEcCtD
Tiagabine—Headache—Sunitinib—pancreatic cancer	0.000438	0.000563	CcSEcCtD
Tiagabine—Syncope—Docetaxel—pancreatic cancer	0.000437	0.000562	CcSEcCtD
Tiagabine—Influenza—Doxorubicin—pancreatic cancer	0.000437	0.000561	CcSEcCtD
Tiagabine—Asthma—Doxorubicin—pancreatic cancer	0.000437	0.000561	CcSEcCtD
Tiagabine—Dysphagia—Doxorubicin—pancreatic cancer	0.000437	0.000561	CcSEcCtD
Tiagabine—Leukopenia—Docetaxel—pancreatic cancer	0.000436	0.000561	CcSEcCtD
Tiagabine—Pollakiuria—Epirubicin—pancreatic cancer	0.000436	0.00056	CcSEcCtD
Tiagabine—Body temperature increased—Fluorouracil—pancreatic cancer	0.000436	0.00056	CcSEcCtD
Tiagabine—Palpitations—Docetaxel—pancreatic cancer	0.000431	0.000554	CcSEcCtD
Tiagabine—Photosensitivity reaction—Epirubicin—pancreatic cancer	0.000431	0.000554	CcSEcCtD
Tiagabine—Weight increased—Epirubicin—pancreatic cancer	0.000429	0.000552	CcSEcCtD
Tiagabine—Loss of consciousness—Docetaxel—pancreatic cancer	0.000428	0.000551	CcSEcCtD
Tiagabine—Weight decreased—Epirubicin—pancreatic cancer	0.000427	0.000549	CcSEcCtD
Tiagabine—Hyperglycaemia—Epirubicin—pancreatic cancer	0.000426	0.000547	CcSEcCtD
Tiagabine—Cough—Docetaxel—pancreatic cancer	0.000425	0.000547	CcSEcCtD
Tiagabine—Angina pectoris—Doxorubicin—pancreatic cancer	0.000425	0.000547	CcSEcCtD
Tiagabine—Hypersensitivity—Irinotecan—pancreatic cancer	0.000424	0.000545	CcSEcCtD
Tiagabine—Pneumonia—Epirubicin—pancreatic cancer	0.000423	0.000544	CcSEcCtD
Tiagabine—Hypertension—Docetaxel—pancreatic cancer	0.000421	0.000541	CcSEcCtD
Tiagabine—Bronchitis—Doxorubicin—pancreatic cancer	0.00042	0.00054	CcSEcCtD
Tiagabine—Myalgia—Docetaxel—pancreatic cancer	0.000415	0.000534	CcSEcCtD
Tiagabine—Arthralgia—Docetaxel—pancreatic cancer	0.000415	0.000534	CcSEcCtD
Tiagabine—Chest pain—Docetaxel—pancreatic cancer	0.000415	0.000534	CcSEcCtD
Tiagabine—Nausea—Sunitinib—pancreatic cancer	0.000415	0.000534	CcSEcCtD
Tiagabine—Renal failure—Epirubicin—pancreatic cancer	0.000414	0.000532	CcSEcCtD
Tiagabine—Asthenia—Irinotecan—pancreatic cancer	0.000413	0.000531	CcSEcCtD
Tiagabine—Neuropathy peripheral—Epirubicin—pancreatic cancer	0.000412	0.00053	CcSEcCtD
Tiagabine—Stomatitis—Epirubicin—pancreatic cancer	0.00041	0.000527	CcSEcCtD
Tiagabine—Conjunctivitis—Epirubicin—pancreatic cancer	0.000409	0.000526	CcSEcCtD
Tiagabine—Urinary tract infection—Epirubicin—pancreatic cancer	0.000409	0.000526	CcSEcCtD
Tiagabine—Dysuria—Doxorubicin—pancreatic cancer	0.000408	0.000525	CcSEcCtD
Tiagabine—Hypersensitivity—Fluorouracil—pancreatic cancer	0.000406	0.000522	CcSEcCtD
Tiagabine—Dry mouth—Docetaxel—pancreatic cancer	0.000406	0.000522	CcSEcCtD
Tiagabine—Sweating—Epirubicin—pancreatic cancer	0.000403	0.000519	CcSEcCtD
Tiagabine—Pollakiuria—Doxorubicin—pancreatic cancer	0.000403	0.000519	CcSEcCtD
Tiagabine—Asthenia—Gemcitabine—pancreatic cancer	0.000402	0.000517	CcSEcCtD
Tiagabine—Haematuria—Epirubicin—pancreatic cancer	0.000401	0.000516	CcSEcCtD
Tiagabine—Confusional state—Docetaxel—pancreatic cancer	0.000401	0.000516	CcSEcCtD
Tiagabine—Photosensitivity reaction—Doxorubicin—pancreatic cancer	0.000399	0.000512	CcSEcCtD
Tiagabine—Oedema—Docetaxel—pancreatic cancer	0.000398	0.000511	CcSEcCtD
Tiagabine—Weight increased—Doxorubicin—pancreatic cancer	0.000397	0.000511	CcSEcCtD
Tiagabine—Epistaxis—Epirubicin—pancreatic cancer	0.000397	0.00051	CcSEcCtD
Tiagabine—Pruritus—Gemcitabine—pancreatic cancer	0.000397	0.00051	CcSEcCtD
Tiagabine—Infection—Docetaxel—pancreatic cancer	0.000395	0.000508	CcSEcCtD
Tiagabine—Weight decreased—Doxorubicin—pancreatic cancer	0.000395	0.000508	CcSEcCtD
Tiagabine—Sinusitis—Epirubicin—pancreatic cancer	0.000395	0.000507	CcSEcCtD
Tiagabine—Hyperglycaemia—Doxorubicin—pancreatic cancer	0.000394	0.000506	CcSEcCtD
Tiagabine—Diarrhoea—Irinotecan—pancreatic cancer	0.000394	0.000506	CcSEcCtD
Tiagabine—Pneumonia—Doxorubicin—pancreatic cancer	0.000392	0.000503	CcSEcCtD
Tiagabine—Shock—Docetaxel—pancreatic cancer	0.000391	0.000503	CcSEcCtD
Tiagabine—Pruritus—Fluorouracil—pancreatic cancer	0.00039	0.000501	CcSEcCtD
Tiagabine—Thrombocytopenia—Docetaxel—pancreatic cancer	0.000389	0.000501	CcSEcCtD
Tiagabine—Tachycardia—Docetaxel—pancreatic cancer	0.000388	0.000499	CcSEcCtD
Tiagabine—Diarrhoea—Gemcitabine—pancreatic cancer	0.000384	0.000493	CcSEcCtD
Tiagabine—Renal failure—Doxorubicin—pancreatic cancer	0.000383	0.000492	CcSEcCtD
Tiagabine—Neuropathy peripheral—Doxorubicin—pancreatic cancer	0.000382	0.000491	CcSEcCtD
Tiagabine—Dizziness—Irinotecan—pancreatic cancer	0.000381	0.000489	CcSEcCtD
Tiagabine—Haemoglobin—Epirubicin—pancreatic cancer	0.00038	0.000488	CcSEcCtD
Tiagabine—Stomatitis—Doxorubicin—pancreatic cancer	0.000379	0.000488	CcSEcCtD
Tiagabine—Anorexia—Docetaxel—pancreatic cancer	0.000379	0.000488	CcSEcCtD
Tiagabine—Rhinitis—Epirubicin—pancreatic cancer	0.000379	0.000487	CcSEcCtD
Tiagabine—Urinary tract infection—Doxorubicin—pancreatic cancer	0.000378	0.000486	CcSEcCtD
Tiagabine—Conjunctivitis—Doxorubicin—pancreatic cancer	0.000378	0.000486	CcSEcCtD
Tiagabine—Haemorrhage—Epirubicin—pancreatic cancer	0.000378	0.000486	CcSEcCtD
Tiagabine—Diarrhoea—Fluorouracil—pancreatic cancer	0.000377	0.000485	CcSEcCtD
Tiagabine—Hypoaesthesia—Epirubicin—pancreatic cancer	0.000376	0.000483	CcSEcCtD
Tiagabine—Pharyngitis—Epirubicin—pancreatic cancer	0.000375	0.000482	CcSEcCtD
Tiagabine—Sweating—Doxorubicin—pancreatic cancer	0.000373	0.00048	CcSEcCtD
Tiagabine—Oedema peripheral—Epirubicin—pancreatic cancer	0.000372	0.000478	CcSEcCtD
Tiagabine—Hypotension—Docetaxel—pancreatic cancer	0.000372	0.000478	CcSEcCtD
Tiagabine—Haematuria—Doxorubicin—pancreatic cancer	0.000371	0.000477	CcSEcCtD
Tiagabine—Epistaxis—Doxorubicin—pancreatic cancer	0.000367	0.000472	CcSEcCtD
Tiagabine—Vomiting—Irinotecan—pancreatic cancer	0.000366	0.00047	CcSEcCtD
Tiagabine—Sinusitis—Doxorubicin—pancreatic cancer	0.000365	0.00047	CcSEcCtD
Tiagabine—Dizziness—Fluorouracil—pancreatic cancer	0.000364	0.000469	CcSEcCtD
Tiagabine—Visual impairment—Epirubicin—pancreatic cancer	0.000364	0.000468	CcSEcCtD
Tiagabine—Rash—Irinotecan—pancreatic cancer	0.000363	0.000467	CcSEcCtD
Tiagabine—Dermatitis—Irinotecan—pancreatic cancer	0.000363	0.000466	CcSEcCtD
Tiagabine—Musculoskeletal discomfort—Docetaxel—pancreatic cancer	0.000362	0.000466	CcSEcCtD
Tiagabine—Headache—Irinotecan—pancreatic cancer	0.000361	0.000464	CcSEcCtD
Tiagabine—Insomnia—Docetaxel—pancreatic cancer	0.00036	0.000463	CcSEcCtD
Tiagabine—Paraesthesia—Docetaxel—pancreatic cancer	0.000357	0.000459	CcSEcCtD
Tiagabine—Vomiting—Gemcitabine—pancreatic cancer	0.000356	0.000458	CcSEcCtD
Tiagabine—Dyspnoea—Docetaxel—pancreatic cancer	0.000355	0.000456	CcSEcCtD
Tiagabine—Somnolence—Docetaxel—pancreatic cancer	0.000354	0.000455	CcSEcCtD
Tiagabine—Rash—Gemcitabine—pancreatic cancer	0.000353	0.000454	CcSEcCtD
Tiagabine—Dermatitis—Gemcitabine—pancreatic cancer	0.000353	0.000454	CcSEcCtD
Tiagabine—Tinnitus—Epirubicin—pancreatic cancer	0.000352	0.000453	CcSEcCtD
Tiagabine—Haemoglobin—Doxorubicin—pancreatic cancer	0.000351	0.000452	CcSEcCtD
Tiagabine—Headache—Gemcitabine—pancreatic cancer	0.000351	0.000452	CcSEcCtD
Tiagabine—Vomiting—Fluorouracil—pancreatic cancer	0.00035	0.000451	CcSEcCtD
Tiagabine—Rhinitis—Doxorubicin—pancreatic cancer	0.00035	0.00045	CcSEcCtD
Tiagabine—Dyspepsia—Docetaxel—pancreatic cancer	0.00035	0.00045	CcSEcCtD
Tiagabine—Haemorrhage—Doxorubicin—pancreatic cancer	0.000349	0.000449	CcSEcCtD
Tiagabine—Hypoaesthesia—Doxorubicin—pancreatic cancer	0.000348	0.000447	CcSEcCtD
Tiagabine—Rash—Fluorouracil—pancreatic cancer	0.000348	0.000447	CcSEcCtD
Tiagabine—Dermatitis—Fluorouracil—pancreatic cancer	0.000347	0.000446	CcSEcCtD
Tiagabine—Pharyngitis—Doxorubicin—pancreatic cancer	0.000347	0.000446	CcSEcCtD
Tiagabine—Decreased appetite—Docetaxel—pancreatic cancer	0.000346	0.000445	CcSEcCtD
Tiagabine—Headache—Fluorouracil—pancreatic cancer	0.000345	0.000444	CcSEcCtD
Tiagabine—Oedema peripheral—Doxorubicin—pancreatic cancer	0.000344	0.000443	CcSEcCtD
Tiagabine—Fatigue—Docetaxel—pancreatic cancer	0.000343	0.000441	CcSEcCtD
Tiagabine—Nausea—Irinotecan—pancreatic cancer	0.000342	0.000439	CcSEcCtD
Tiagabine—Pain—Docetaxel—pancreatic cancer	0.00034	0.000437	CcSEcCtD
Tiagabine—Constipation—Docetaxel—pancreatic cancer	0.00034	0.000437	CcSEcCtD
Tiagabine—Chills—Epirubicin—pancreatic cancer	0.000339	0.000436	CcSEcCtD
Tiagabine—Visual impairment—Doxorubicin—pancreatic cancer	0.000337	0.000433	CcSEcCtD
Tiagabine—Alopecia—Epirubicin—pancreatic cancer	0.000334	0.000429	CcSEcCtD
Tiagabine—Nausea—Gemcitabine—pancreatic cancer	0.000333	0.000428	CcSEcCtD
Tiagabine—Feeling abnormal—Docetaxel—pancreatic cancer	0.000328	0.000421	CcSEcCtD
Tiagabine—Nausea—Fluorouracil—pancreatic cancer	0.000327	0.000421	CcSEcCtD
Tiagabine—Tinnitus—Doxorubicin—pancreatic cancer	0.000326	0.000419	CcSEcCtD
Tiagabine—Gastrointestinal pain—Docetaxel—pancreatic cancer	0.000325	0.000418	CcSEcCtD
Tiagabine—Flatulence—Epirubicin—pancreatic cancer	0.000324	0.000417	CcSEcCtD
Tiagabine—Tension—Epirubicin—pancreatic cancer	0.000323	0.000415	CcSEcCtD
Tiagabine—Dysgeusia—Epirubicin—pancreatic cancer	0.000322	0.000414	CcSEcCtD
Tiagabine—Nervousness—Epirubicin—pancreatic cancer	0.000319	0.000411	CcSEcCtD
Tiagabine—Back pain—Epirubicin—pancreatic cancer	0.000318	0.000409	CcSEcCtD
Tiagabine—Muscle spasms—Epirubicin—pancreatic cancer	0.000316	0.000406	CcSEcCtD
Tiagabine—Abdominal pain—Docetaxel—pancreatic cancer	0.000314	0.000404	CcSEcCtD
Tiagabine—Body temperature increased—Docetaxel—pancreatic cancer	0.000314	0.000404	CcSEcCtD
Tiagabine—Chills—Doxorubicin—pancreatic cancer	0.000314	0.000403	CcSEcCtD
Tiagabine—Alopecia—Doxorubicin—pancreatic cancer	0.000309	0.000397	CcSEcCtD
Tiagabine—Ill-defined disorder—Epirubicin—pancreatic cancer	0.000305	0.000392	CcSEcCtD
Tiagabine—Anaemia—Epirubicin—pancreatic cancer	0.000304	0.000391	CcSEcCtD
Tiagabine—Agitation—Epirubicin—pancreatic cancer	0.000302	0.000388	CcSEcCtD
Tiagabine—Flatulence—Doxorubicin—pancreatic cancer	0.0003	0.000385	CcSEcCtD
Tiagabine—Tension—Doxorubicin—pancreatic cancer	0.000299	0.000384	CcSEcCtD
Tiagabine—Dysgeusia—Doxorubicin—pancreatic cancer	0.000298	0.000383	CcSEcCtD
Tiagabine—Malaise—Epirubicin—pancreatic cancer	0.000296	0.000381	CcSEcCtD
Tiagabine—Nervousness—Doxorubicin—pancreatic cancer	0.000295	0.00038	CcSEcCtD
Tiagabine—Vertigo—Epirubicin—pancreatic cancer	0.000295	0.00038	CcSEcCtD
Tiagabine—Syncope—Epirubicin—pancreatic cancer	0.000295	0.000379	CcSEcCtD
Tiagabine—Leukopenia—Epirubicin—pancreatic cancer	0.000294	0.000378	CcSEcCtD
Tiagabine—Back pain—Doxorubicin—pancreatic cancer	0.000294	0.000378	CcSEcCtD
Tiagabine—Hypersensitivity—Docetaxel—pancreatic cancer	0.000293	0.000377	CcSEcCtD
Tiagabine—Muscle spasms—Doxorubicin—pancreatic cancer	0.000292	0.000376	CcSEcCtD
Tiagabine—Palpitations—Epirubicin—pancreatic cancer	0.000291	0.000374	CcSEcCtD
Tiagabine—Loss of consciousness—Epirubicin—pancreatic cancer	0.000289	0.000372	CcSEcCtD
Tiagabine—Cough—Epirubicin—pancreatic cancer	0.000287	0.000369	CcSEcCtD
Tiagabine—Asthenia—Docetaxel—pancreatic cancer	0.000285	0.000367	CcSEcCtD
Tiagabine—Hypertension—Epirubicin—pancreatic cancer	0.000284	0.000365	CcSEcCtD
Tiagabine—Ill-defined disorder—Doxorubicin—pancreatic cancer	0.000282	0.000363	CcSEcCtD
Tiagabine—Pruritus—Docetaxel—pancreatic cancer	0.000281	0.000362	CcSEcCtD
Tiagabine—Anaemia—Doxorubicin—pancreatic cancer	0.000281	0.000361	CcSEcCtD
Tiagabine—Arthralgia—Epirubicin—pancreatic cancer	0.00028	0.00036	CcSEcCtD
Tiagabine—Chest pain—Epirubicin—pancreatic cancer	0.00028	0.00036	CcSEcCtD
Tiagabine—Myalgia—Epirubicin—pancreatic cancer	0.00028	0.00036	CcSEcCtD
Tiagabine—Agitation—Doxorubicin—pancreatic cancer	0.00028	0.000359	CcSEcCtD
Tiagabine—Anxiety—Epirubicin—pancreatic cancer	0.000279	0.000359	CcSEcCtD
Tiagabine—Discomfort—Epirubicin—pancreatic cancer	0.000277	0.000356	CcSEcCtD
Tiagabine—Malaise—Doxorubicin—pancreatic cancer	0.000274	0.000353	CcSEcCtD
Tiagabine—Dry mouth—Epirubicin—pancreatic cancer	0.000274	0.000352	CcSEcCtD
Tiagabine—Vertigo—Doxorubicin—pancreatic cancer	0.000273	0.000351	CcSEcCtD
Tiagabine—Syncope—Doxorubicin—pancreatic cancer	0.000273	0.000351	CcSEcCtD
Tiagabine—Leukopenia—Doxorubicin—pancreatic cancer	0.000272	0.00035	CcSEcCtD
Tiagabine—Diarrhoea—Docetaxel—pancreatic cancer	0.000272	0.00035	CcSEcCtD
Tiagabine—Confusional state—Epirubicin—pancreatic cancer	0.000271	0.000348	CcSEcCtD
Tiagabine—Palpitations—Doxorubicin—pancreatic cancer	0.000269	0.000346	CcSEcCtD
Tiagabine—Oedema—Epirubicin—pancreatic cancer	0.000268	0.000345	CcSEcCtD
Tiagabine—Loss of consciousness—Doxorubicin—pancreatic cancer	0.000267	0.000344	CcSEcCtD
Tiagabine—Infection—Epirubicin—pancreatic cancer	0.000267	0.000343	CcSEcCtD
Tiagabine—Cough—Doxorubicin—pancreatic cancer	0.000265	0.000341	CcSEcCtD
Tiagabine—Shock—Epirubicin—pancreatic cancer	0.000264	0.000339	CcSEcCtD
Tiagabine—Dizziness—Docetaxel—pancreatic cancer	0.000263	0.000338	CcSEcCtD
Tiagabine—Thrombocytopenia—Epirubicin—pancreatic cancer	0.000263	0.000338	CcSEcCtD
Tiagabine—Hypertension—Doxorubicin—pancreatic cancer	0.000263	0.000338	CcSEcCtD
Tiagabine—Tachycardia—Epirubicin—pancreatic cancer	0.000262	0.000337	CcSEcCtD
Tiagabine—Hyperhidrosis—Epirubicin—pancreatic cancer	0.000259	0.000334	CcSEcCtD
Tiagabine—Myalgia—Doxorubicin—pancreatic cancer	0.000259	0.000333	CcSEcCtD
Tiagabine—Chest pain—Doxorubicin—pancreatic cancer	0.000259	0.000333	CcSEcCtD
Tiagabine—Arthralgia—Doxorubicin—pancreatic cancer	0.000259	0.000333	CcSEcCtD
Tiagabine—Anxiety—Doxorubicin—pancreatic cancer	0.000258	0.000332	CcSEcCtD
Tiagabine—Discomfort—Doxorubicin—pancreatic cancer	0.000256	0.000329	CcSEcCtD
Tiagabine—Anorexia—Epirubicin—pancreatic cancer	0.000256	0.000329	CcSEcCtD
Tiagabine—Dry mouth—Doxorubicin—pancreatic cancer	0.000253	0.000326	CcSEcCtD
Tiagabine—Vomiting—Docetaxel—pancreatic cancer	0.000253	0.000325	CcSEcCtD
Tiagabine—Rash—Docetaxel—pancreatic cancer	0.000251	0.000322	CcSEcCtD
Tiagabine—Hypotension—Epirubicin—pancreatic cancer	0.000251	0.000322	CcSEcCtD
Tiagabine—Dermatitis—Docetaxel—pancreatic cancer	0.000251	0.000322	CcSEcCtD
Tiagabine—Confusional state—Doxorubicin—pancreatic cancer	0.00025	0.000322	CcSEcCtD
Tiagabine—Headache—Docetaxel—pancreatic cancer	0.000249	0.00032	CcSEcCtD
Tiagabine—Oedema—Doxorubicin—pancreatic cancer	0.000248	0.000319	CcSEcCtD
Tiagabine—Infection—Doxorubicin—pancreatic cancer	0.000247	0.000317	CcSEcCtD
Tiagabine—Musculoskeletal discomfort—Epirubicin—pancreatic cancer	0.000244	0.000314	CcSEcCtD
Tiagabine—Shock—Doxorubicin—pancreatic cancer	0.000244	0.000314	CcSEcCtD
Tiagabine—Thrombocytopenia—Doxorubicin—pancreatic cancer	0.000243	0.000313	CcSEcCtD
Tiagabine—Insomnia—Epirubicin—pancreatic cancer	0.000243	0.000312	CcSEcCtD
Tiagabine—Tachycardia—Doxorubicin—pancreatic cancer	0.000242	0.000312	CcSEcCtD
Tiagabine—Paraesthesia—Epirubicin—pancreatic cancer	0.000241	0.00031	CcSEcCtD
Tiagabine—Hyperhidrosis—Doxorubicin—pancreatic cancer	0.00024	0.000309	CcSEcCtD
Tiagabine—Dyspnoea—Epirubicin—pancreatic cancer	0.000239	0.000308	CcSEcCtD
Tiagabine—Somnolence—Epirubicin—pancreatic cancer	0.000239	0.000307	CcSEcCtD
Tiagabine—Anorexia—Doxorubicin—pancreatic cancer	0.000237	0.000304	CcSEcCtD
Tiagabine—Nausea—Docetaxel—pancreatic cancer	0.000236	0.000304	CcSEcCtD
Tiagabine—Dyspepsia—Epirubicin—pancreatic cancer	0.000236	0.000304	CcSEcCtD
Tiagabine—Decreased appetite—Epirubicin—pancreatic cancer	0.000233	0.0003	CcSEcCtD
Tiagabine—Hypotension—Doxorubicin—pancreatic cancer	0.000232	0.000298	CcSEcCtD
Tiagabine—Fatigue—Epirubicin—pancreatic cancer	0.000231	0.000297	CcSEcCtD
Tiagabine—Pain—Epirubicin—pancreatic cancer	0.000229	0.000295	CcSEcCtD
Tiagabine—Constipation—Epirubicin—pancreatic cancer	0.000229	0.000295	CcSEcCtD
Tiagabine—Musculoskeletal discomfort—Doxorubicin—pancreatic cancer	0.000226	0.000291	CcSEcCtD
Tiagabine—Insomnia—Doxorubicin—pancreatic cancer	0.000225	0.000289	CcSEcCtD
Tiagabine—Paraesthesia—Doxorubicin—pancreatic cancer	0.000223	0.000287	CcSEcCtD
Tiagabine—Dyspnoea—Doxorubicin—pancreatic cancer	0.000221	0.000285	CcSEcCtD
Tiagabine—Feeling abnormal—Epirubicin—pancreatic cancer	0.000221	0.000284	CcSEcCtD
Tiagabine—Somnolence—Doxorubicin—pancreatic cancer	0.000221	0.000284	CcSEcCtD
Tiagabine—Gastrointestinal pain—Epirubicin—pancreatic cancer	0.000219	0.000282	CcSEcCtD
Tiagabine—Dyspepsia—Doxorubicin—pancreatic cancer	0.000219	0.000281	CcSEcCtD
Tiagabine—Decreased appetite—Doxorubicin—pancreatic cancer	0.000216	0.000277	CcSEcCtD
Tiagabine—Fatigue—Doxorubicin—pancreatic cancer	0.000214	0.000275	CcSEcCtD
Tiagabine—Urticaria—Epirubicin—pancreatic cancer	0.000213	0.000274	CcSEcCtD
Tiagabine—Pain—Doxorubicin—pancreatic cancer	0.000212	0.000273	CcSEcCtD
Tiagabine—Constipation—Doxorubicin—pancreatic cancer	0.000212	0.000273	CcSEcCtD
Tiagabine—Abdominal pain—Epirubicin—pancreatic cancer	0.000212	0.000273	CcSEcCtD
Tiagabine—Body temperature increased—Epirubicin—pancreatic cancer	0.000212	0.000273	CcSEcCtD
Tiagabine—Feeling abnormal—Doxorubicin—pancreatic cancer	0.000205	0.000263	CcSEcCtD
Tiagabine—Gastrointestinal pain—Doxorubicin—pancreatic cancer	0.000203	0.000261	CcSEcCtD
Tiagabine—Hypersensitivity—Epirubicin—pancreatic cancer	0.000198	0.000254	CcSEcCtD
Tiagabine—Urticaria—Doxorubicin—pancreatic cancer	0.000197	0.000254	CcSEcCtD
Tiagabine—Body temperature increased—Doxorubicin—pancreatic cancer	0.000196	0.000252	CcSEcCtD
Tiagabine—Abdominal pain—Doxorubicin—pancreatic cancer	0.000196	0.000252	CcSEcCtD
Tiagabine—Asthenia—Epirubicin—pancreatic cancer	0.000193	0.000248	CcSEcCtD
Tiagabine—Pruritus—Epirubicin—pancreatic cancer	0.00019	0.000244	CcSEcCtD
Tiagabine—Diarrhoea—Epirubicin—pancreatic cancer	0.000184	0.000236	CcSEcCtD
Tiagabine—Hypersensitivity—Doxorubicin—pancreatic cancer	0.000183	0.000235	CcSEcCtD
Tiagabine—Asthenia—Doxorubicin—pancreatic cancer	0.000178	0.000229	CcSEcCtD
Tiagabine—Dizziness—Epirubicin—pancreatic cancer	0.000177	0.000228	CcSEcCtD
Tiagabine—Pruritus—Doxorubicin—pancreatic cancer	0.000176	0.000226	CcSEcCtD
Tiagabine—Vomiting—Epirubicin—pancreatic cancer	0.000171	0.000219	CcSEcCtD
Tiagabine—Diarrhoea—Doxorubicin—pancreatic cancer	0.00017	0.000218	CcSEcCtD
Tiagabine—Rash—Epirubicin—pancreatic cancer	0.000169	0.000218	CcSEcCtD
Tiagabine—Dermatitis—Epirubicin—pancreatic cancer	0.000169	0.000217	CcSEcCtD
Tiagabine—Headache—Epirubicin—pancreatic cancer	0.000168	0.000216	CcSEcCtD
Tiagabine—Dizziness—Doxorubicin—pancreatic cancer	0.000164	0.000211	CcSEcCtD
Tiagabine—Nausea—Epirubicin—pancreatic cancer	0.000159	0.000205	CcSEcCtD
Tiagabine—Vomiting—Doxorubicin—pancreatic cancer	0.000158	0.000203	CcSEcCtD
Tiagabine—Rash—Doxorubicin—pancreatic cancer	0.000157	0.000201	CcSEcCtD
Tiagabine—Dermatitis—Doxorubicin—pancreatic cancer	0.000156	0.000201	CcSEcCtD
Tiagabine—Headache—Doxorubicin—pancreatic cancer	0.000156	0.0002	CcSEcCtD
Tiagabine—Nausea—Doxorubicin—pancreatic cancer	0.000147	0.00019	CcSEcCtD
